Other Clinical Trial - A Comparative Bioavailability Study of Lisinopril

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R).

To compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc. Zestril (R), 40 mg - Effect of Food Study ;

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label

See also
Status	Clinical Trial	Phase
Completed	`NCT00652600` - Bioavailability Study of Propranolol Under Fed Conditions	Phase 1
Completed	`NCT01380496` - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652821` - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652873` - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions	Phase 1
Completed	`NCT00652704` - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions	Phase 1
Completed	`NCT00652730` - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions	Phase 1
Completed	`NCT05329857` - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.	N/A
Completed	`NCT05337969` - The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.	N/A
Completed	`NCT00653003` - Bioavailability Study of Leflunomide Tablets Under Fed Conditions	Phase 1